Anthony Sabatelli Joins Wiggin and Dana as Patent Counsel in Intellectual Property and Life Sciences Practice Groups

February 4, 2019

Wiggin and Dana is pleased to announce that Anthony Sabatelli has joined the firm as Patent Counsel in Wiggin and Dana’s Intellectual Property and Life Sciences practice groups. Dr. Sabatelli is a former business executive with both in-house corporate and law firm experience, with specific expertise in biotechnology. Dr. Sabatelli is a seasoned intellectual property attorney, and is well-versed in patent and Hatch-Waxman and regulatory law. In fact, he began his career as a research scientist and project manager, and is an inventor on numerous patents.

Although Dr. Sabatelli focuses his patent practice on the life sciences, his patent experience covers a broad array of technologies, including pharmaceuticals, small molecules, macromolecules, RNA and DNA, proteins, biotechnology, drug delivery systems, inorganic chemistry and metals, medical devices, polymers, personal care products, formulations, process chemistry, X-ray crystallography, mechanical devices, green chemistry, software, nanotechnology, analytical methods, research tools, and blockchain technology. Services that he provides to his clients include, patent preparation and prosecution, foreign patent prosecution, patent searching and interpretation, patentability opinions, freedom-of-operation opinions, and landscape and competitive intelligence analyses.

Before joining Wiggin and Dana, Dr. Sabatelli was Partner and Chair of the Biotech and Life Sciences Practice at a boutique law firm in Connecticut. Previously, he was Vice President and General Counsel and Chief Patent Counsel at Melinta Therapeutics, Inc., Assistant Counsel at Merck & Co., Inc. and Patent Counsel at Procter & Gamble.